Latest Updates
-
Diwali 2026: Chakli To Nimki, 7 Regional Savoury Snacks That Bring Traditional Indian Flavours To Your Table -
Filmmaker Sanjay Gupta Passes Away At 57: ‘Aatish’ To ‘Kaabil’, Look At His Three-Decade Bollywood Journey -
Halloween 2026: From Chudail To Yakshi, 5 Mysterious Supernatural Beings That Haunt Indian Folklore -
Rashtriya Ekta Diwas 2026: Significance, History And Sardar Vallabhbhai Patel's Role In Uniting India -
Survey Finds 68% Of Previously Married Singles Hesitate To Match With Never-Married Partners -
Diwali 2026: Complete Five-Day Festival Calendar, Dates, Significance And Celebrations -
Weight, Alcohol, Hormones: Pathologist Shares Insights On What Really Shapes A Woman’s Breast Cancer Risk -
Diwali 2026: 5 Healthy Homemade Indian Sweets That Go Beyond Traditional Mithai -
Stroke In Young Women: Neurologist Explains Warning Signs And Hormonal Risk Factors -
‘Star Trek’ And ‘X-Men’ Actor Patrick Stewart Passes Away At 86 After Dementia Battle
Women With Breast Lesions

The study from the Group Health Center for Health Studies, authored by Erin J. Aiello Bowles, MPH, has found that six-month short-interval follow-up examinations had 83 percent sensitivity, which is similar to the sensitivity of other diagnostic mammograms.
High sensitivity implies identifying a high proportion of “true positives" (actual cancer cases) and a low proportion of “false negatives" (cases mistakenly deemed benign).
The study involved 45,007 initial short-interval follow-up mammograms.
“Short-interval follow-up mammograms are done to monitor for changes in 'probably benign" breast lesions (findings seen on mammograms that have a very low probability of being cancer). Because the probability of cancer is so low, we don't want to put the patient through an unnecessary biopsy, which is an invasive procedure that increases both patient anxiety and medical costs," said Aiello Bowles.
“At the same time, we want to closely monitor these patients, because changes in 'probably benign" lesions occasionally mean cancer, and we want to detect the cancers as early as possible," she said.
Aiello Bowles said that during the study, the researchers diagnosed breast cancer in 360 women with “probably benign" lesions within six months; and 506 women were diagnosed with cancer within 12 months (altogether about one in 100 of the “probably benign" lesions).
“The Breast Imaging-Reporting and Data System (BI-RADS) recommends that women with a BI-RADS category 3 (probably benign) lesion get a six-month diagnostic mammogram, with follow-up continued for the next two to three years until long-term stability is demonstrated.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
